{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:27:35Z","timestamp":1793226455954,"version":"4.5.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T00:00:00Z","timestamp":1719360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cartilage, an important connective tissue, provides structural support to other body tissues, and serves as a cushion against impacts throughout the body. Found at the end of the bones, cartilage decreases friction and averts bone-on-bone contact during joint movement. Therefore, defects of cartilage can result from natural wear and tear, or from traumatic events, such as injuries or sudden changes in direction during sports activities. Overtime, these cartilage defects which do not always produce immediate symptoms, could lead to severe clinical pathologies. The emergence of induced pluripotent stem cells (iPSCs) has revolutionized the field of regenerative medicine, providing a promising platform for generating various cell types for therapeutic applications. Thus, chondrocytes differentiated from iPSCs become a promising avenue for non-invasive clinical interventions for cartilage injuries and diseases. In this review, we aim to highlight the current strategies used for in vitro chondrogenic differentiation of iPSCs and to explore their multifaceted applications in disease modeling, drug screening, and personalized regenerative medicine. Achieving abundant functional iPSC-derived chondrocytes requires optimization of culture conditions, incorporating specific growth factors, and precise temporal control. Continual improvements in differentiation methods and integration of emerging genome editing, organoids, and 3D bioprinting technologies will enhance the translational applications of iPSC-derived chondrocytes. Finally, to unlock the benefits for patients suffering from cartilage diseases through iPSCs-derived technologies in chondrogenesis, automatic cell therapy manufacturing systems will not only reduce human intervention and ensure sterile processes within isolator-like platforms to minimize contamination risks, but also provide customized production processes with enhanced scalability and efficiency.<\/jats:p>\n                <jats:p><jats:bold>Graphical abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s13287-024-03794-1","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T15:02:18Z","timestamp":1719414138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["iPSCs chondrogenic differentiation for personalized regenerative medicine: a literature review"],"prefix":"10.1186","volume":"15","author":[{"given":"Eltahir Abdelrazig Mohamed","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Smaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongchao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Benkirane-Jessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques Eric","family":"Gottenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7639-5908","authenticated-orcid":false,"given":"Guoqiang","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,26]]},"reference":[{"key":"3794_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.matbio.2018.05.005","volume":"71\u201372","author":"Y Krishnan","year":"2018","unstructured":"Krishnan Y, Grodzinsky AJ. Cartilage diseases. Matrix Biol. 2018;71\u201372:51\u201369.","journal-title":"Matrix Biol"},{"key":"3794_CR2","doi-asserted-by":"crossref","unstructured":"Sha\u2019ban M. Histology and biomechanics of cartilage. Cartil Tissue Knee Jt Biomech [Internet]. Elsevier; 2024 [cited 2024 Feb 9]. pp. 25\u201335. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780323905978000013","DOI":"10.1016\/B978-0-323-90597-8.00001-3"},{"key":"3794_CR3","first-page":"155","volume-title":"Robotics applications in total knee arthroplasty. Total knee arthroplasty","author":"E Tokgoz","year":"2023","unstructured":"Tokgoz E, Levitt S, Sosa D, Carola NA, Patel V. Robotics applications in total knee arthroplasty. Total knee arthroplasty. Cham: Springer Nature Switzerland; 2023. p. 155\u201374."},{"key":"3794_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2015.06.007","volume":"17","author":"A Trounson","year":"2015","unstructured":"Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell. 2015;17:11\u201322.","journal-title":"Cell Stem Cell"},{"key":"3794_CR5","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41536-019-0083-6","volume":"4","author":"MF Pittenger","year":"2019","unstructured":"Pittenger MF, Discher DE, P\u00e9ault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med. 2019;4:22.","journal-title":"NPJ Regen Med"},{"key":"3794_CR6","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8:726\u201336.","journal-title":"Nat Rev Immunol"},{"key":"3794_CR7","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3727\/096368915X689622","volume":"25","author":"T Squillaro","year":"2016","unstructured":"Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell Transpl. 2016;25:829\u201348.","journal-title":"Cell Transpl"},{"key":"3794_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0092-8674(01)00622-5","volume":"108","author":"K Nakashima","year":"2002","unstructured":"Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell. 2002;108:17\u201329.","journal-title":"Cell"},{"key":"3794_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/ng1015","volume":"32","author":"CA Yoshida","year":"2002","unstructured":"Yoshida CA, Furuichi T, Fujita T, Fukuyama R, Kanatani N, Kobayashi S, et al. Core-binding factor \u03b2 interacts with Runx2 and is required for skeletal development. Nat Genet. 2002;32:633\u20138.","journal-title":"Nat Genet"},{"key":"3794_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1186\/s13287-020-02001-1","volume":"11","author":"P Kangari","year":"2020","unstructured":"Kangari P, Talaei-Khozani T, Razeghian-Jahromi I, Razmkhah M. Mesenchymal stem cells: amazing remedies for bone and cartilage defects. Stem Cell Res Ther. 2020;11:492.","journal-title":"Stem Cell Res Ther"},{"key":"3794_CR11","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1089\/ten.teb.2013.0771","volume":"20","author":"RA Somoza","year":"2014","unstructured":"Somoza RA, Welter JF, Correa D, Caplan AI. Chondrogenic differentiation of mesenchymal stem cells: challenges and unfulfilled expectations. Tissue Eng Part B Rev. 2014;20:596\u2013608.","journal-title":"Tissue Eng Part B Rev"},{"key":"3794_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12717\/DR.2017.21.1.001","volume":"21","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Park J-S. Usage of human mesenchymal stem cells in cell-based therapy: advantages and disadvantages. Dev Reprod. 2017;21:1\u201310.","journal-title":"Dev Reprod"},{"key":"3794_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jcyt.2012.10.002","volume":"15","author":"J Galipeau","year":"2013","unstructured":"Galipeau J. The mesenchymal stromal cells dilemma\u2014does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road? Cytotherapy. 2013;15:2\u20138.","journal-title":"Cytotherapy"},{"key":"3794_CR14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell"},{"key":"3794_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861\u201372.","journal-title":"Cell"},{"key":"3794_CR16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1152\/physrev.00039.2017","volume":"99","author":"P Karagiannis","year":"2019","unstructured":"Karagiannis P, Takahashi K, Saito M, Yoshida Y, Okita K, Watanabe A, et al. Induced pluripotent stem cells and their use in human models of disease and development. Physiol Rev. 2019;99:79\u2013114.","journal-title":"Physiol Rev"},{"key":"3794_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.stem.2013.01.006","volume":"12","author":"P Guha","year":"2013","unstructured":"Guha P, Morgan JW, Mostoslavsky G, Rodrigues NP, Boyd AS. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell. 2013;12:407\u201312.","journal-title":"Cell Stem Cell"},{"key":"3794_CR18","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/jcb.24388","volume":"114","author":"RM Guzzo","year":"2013","unstructured":"Guzzo RM, Gibson J, Xu R, Lee FY, Drissi H. Efficient differentiation of human iPSC-derived mesenchymal stem cells to chondroprogenitor cells. J Cell Biochem. 2013;114:480\u201390.","journal-title":"J Cell Biochem"},{"key":"3794_CR19","doi-asserted-by":"publisher","first-page":"19172","DOI":"10.1073\/pnas.1210422109","volume":"109","author":"BO Diekman","year":"2012","unstructured":"Diekman BO, Christoforou N, Willard VP, Sun H, Sanchez-Adams J, Leong KW, et al. Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. Proc Natl Acad Sci. 2012;109:19172\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"3794_CR20","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1557\/s43577-023-00551-2","volume":"48","author":"JP Walters-Shumka","year":"2023","unstructured":"Walters-Shumka JP, Sorrentino S, Nygaard HB, Willerth SM. Recent advances in personalized 3D bioprinted tissue models. MRS Bull. 2023;48:632\u201342.","journal-title":"MRS Bull"},{"key":"3794_CR21","first-page":"363","volume-title":"Spontaneous differentiation of human pluripotent stem cells via embryoid body formation. Hum stem cell man","author":"JP Schell","year":"2012","unstructured":"Schell JP. Spontaneous differentiation of human pluripotent stem cells via embryoid body formation. Hum stem cell man. Elsevier; 2012. p. 363\u201373."},{"key":"3794_CR22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/jbmr.4524","volume":"37","author":"P De Kinderen","year":"2020","unstructured":"De Kinderen P, Meester J, Loeys B, Peeters S, Gouze E, Woods S, et al. Differentiation of Induced pluripotent stem cells into chondrocytes: methods and applications for disease modeling and drug discovery. J Bone Miner Res. 2020;37:397\u2013410.","journal-title":"J Bone Miner Res"},{"key":"3794_CR23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/nrn1219","volume":"4","author":"LS Gammill","year":"2003","unstructured":"Gammill LS, Bronner-Fraser M. Neural crest specification: migrating into genomics. Nat Rev Neurosci. 2003;4:795\u2013805.","journal-title":"Nat Rev Neurosci"},{"key":"3794_CR24","doi-asserted-by":"publisher","first-page":"1140717","DOI":"10.3389\/fcell.2023.1140717","volume":"11","author":"D Zujur","year":"2023","unstructured":"Zujur D, Al-Akashi Z, Nakamura A, Zhao C, Takahashi K, Aritomi S, et al. Enhanced chondrogenic differentiation of iPS cell-derived mesenchymal stem\/stromal cells via neural crest cell induction for hyaline cartilage repair. Front Cell Dev Biol. 2023;11:1140717.","journal-title":"Front Cell Dev Biol"},{"key":"3794_CR25","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/nbt.1683","volume":"28","author":"RA Oldershaw","year":"2010","unstructured":"Oldershaw RA, Baxter MA, Lowe ET, Bates N, Grady LM, Soncin F, et al. Directed differentiation of human embryonic stem cells toward chondrocytes. Nat Biotechnol. 2010;28:1187\u201394.","journal-title":"Nat Biotechnol"},{"key":"3794_CR26","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.5966\/sctm.2014-0101","volume":"3","author":"A Cheng","year":"2014","unstructured":"Cheng A, Kapacee Z, Peng J, Lu S, Lucas RJ, Hardingham TE, et al. Cartilage repair using human embryonic stem cell-derived chondroprogenitors. Stem Cells Transl Med. 2014;3:1287\u201394.","journal-title":"Stem Cells Transl Med"},{"key":"3794_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/art.30086","volume":"63","author":"A Aung","year":"2011","unstructured":"Aung A, Gupta G, Majid G, Varghese S. Osteoarthritic chondrocyte\u2013secreted morphogens induce chondrogenic differentiation of human mesenchymal stem cells. Arthritis Rheum. 2011;63:148\u201358.","journal-title":"Arthritis Rheum"},{"key":"3794_CR28","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1634\/stemcells.2004-0062","volume":"22","author":"BC Heng","year":"2004","unstructured":"Heng BC, Cao T, Lee EH. Directing stem cell differentiation into the chondrogenic lineage in vitro. Stem Cells. 2004;22:1152\u201367.","journal-title":"Stem Cells"},{"key":"3794_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.bone.2014.07.011","volume":"70","author":"N Tsumaki","year":"2015","unstructured":"Tsumaki N, Okada M, Yamashita A. iPS cell technologies and cartilage regeneration. Bone. 2015;70:48\u201354.","journal-title":"Bone"},{"key":"3794_CR30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.stemcr.2015.01.016","volume":"4","author":"A Yamashita","year":"2015","unstructured":"Yamashita A, Morioka M, Yahara Y, Okada M, Kobayashi T, Kuriyama S, et al. Generation of scaffoldless hyaline cartilaginous tissue from human iPSCs. Stem Cell Rep. 2015;4:404\u201318.","journal-title":"Stem Cell Rep"},{"key":"3794_CR31","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1089\/scd.2012.0127","volume":"22","author":"N Koyama","year":"2013","unstructured":"Koyama N, Miura M, Nakao K, Kondo E, Fujii T, Taura D, et al. Human induced pluripotent stem cells differentiated into chondrogenic lineage via generation of mesenchymal progenitor cells. Stem Cells Dev. 2013;22:102\u201313.","journal-title":"Stem Cells Dev"},{"key":"3794_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.22203\/eCM.v036a08","volume":"36","author":"R Castro-Vi\u00f1uelas","year":"2018","unstructured":"Castro-Vi\u00f1uelas R, Sanjurjo-Rodr\u00edguez C, Pi\u00f1eiro-Ramil M, Hermida-G\u00f3mez T, Fuentes-Boquete IM, de Toro-Santos FJ, et al. Induced pluripotent stem cells for cartilage repair: current status and future perspectives. Eur Cell Mater. 2018;36:96\u2013109.","journal-title":"Eur Cell Mater"},{"key":"3794_CR33","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s12015-014-9581-5","volume":"11","author":"H Nejadnik","year":"2015","unstructured":"Nejadnik H, Diecke S, Lenkov OD, Chapelin F, Donig J, Tong X, et al. Improved approach for chondrogenic differentiation of human induced pluripotent stem cells. Stem Cell Rev Rep. 2015;11:242\u201353.","journal-title":"Stem Cell Rev Rep"},{"key":"3794_CR34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jcyt.2013.11.004","volume":"16","author":"H Hemeda","year":"2014","unstructured":"Hemeda H, Giebel B, Wagner W. Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells. Cytotherapy. 2014;16:170\u201380.","journal-title":"Cytotherapy"},{"key":"3794_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.biologicals.2011.08.003","volume":"39","author":"C Marcus-Sekura","year":"2011","unstructured":"Marcus-Sekura C, Richardson JC, Harston RK, Sane N, Sheets RL. Evaluation of the human host range of bovine and porcine viruses that may contaminate bovine serum and porcine trypsin used in the manufacture of biological products. Biologicals. 2011;39:359\u201369.","journal-title":"Biologicals"},{"key":"3794_CR36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41536-022-00241-8","volume":"7","author":"D Kamiya","year":"2022","unstructured":"Kamiya D, Takenaka-Ninagawa N, Motoike S, Kajiya M, Akaboshi T, Zhao C, et al. Induction of functional xeno-free MSCs from human iPSCs via a neural crest cell lineage. Npj Regen Med. 2022;7:47.","journal-title":"Npj Regen Med"},{"key":"3794_CR37","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1302\/2046-3758.97.BJR-2019-0364.R2","volume":"9","author":"J Fitzgerald","year":"2020","unstructured":"Fitzgerald J. Applications of CRISPR for musculoskeletal research. Bone Jt Res. 2020;9:351\u20139.","journal-title":"Bone Jt Res"},{"key":"3794_CR38","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11154-023-09860-y","volume":"25","author":"R Vlashi","year":"2023","unstructured":"Vlashi R, Zhang X, Li H, Chen G. Potential therapeutic strategies for osteoarthritis via CRISPR\/Cas9 mediated gene editing. Rev Endocr Metab Disord. 2023;25:339.","journal-title":"Rev Endocr Metab Disord"},{"key":"3794_CR39","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.devcel.2018.07.024","volume":"46","author":"Y Mochizuki","year":"2018","unstructured":"Mochizuki Y, Chiba T, Kataoka K, Yamashita S, Sato T, Kato T, et al. Combinatorial CRISPR\/Cas9 approach to elucidate a far-upstream enhancer complex for tissue-specific Sox9 expression. Dev Cell. 2018;46:794-806.e6.","journal-title":"Dev Cell"},{"key":"3794_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/stem.2931","volume":"37","author":"SS Adkar","year":"2019","unstructured":"Adkar SS, Wu C-L, Willard VP, Dicks A, Ettyreddy A, Steward N, et al. Step-wise chondrogenesis of human induced pluripotent stem cells and purification via a reporter allele generated by CRISPR-Cas9 genome editing. Stem Cells. 2019;37:65\u201376.","journal-title":"Stem Cells"},{"key":"3794_CR41","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1039\/D1BM01716K","volume":"10","author":"HJ Kim","year":"2022","unstructured":"Kim HJ, Park JM, Lee S, Cho HB, Park J-I, Kim J-H, et al. Efficient CRISPR-Cas9-based knockdown of RUNX2 to induce chondrogenic differentiation of stem cells. Biomater Sci. 2022;10:514\u201323.","journal-title":"Biomater Sci"},{"key":"3794_CR42","doi-asserted-by":"publisher","first-page":"102515","DOI":"10.1016\/j.scr.2021.102515","volume":"56","author":"J Lilianty","year":"2021","unstructured":"Lilianty J, Bateman JF, Lamand\u00e9 SR. Generation of a heterozygous COL2A1 (pG1113C) hypochondrogenesis mutation iPSC line, MCRIi019-A-7, using CRISPR\/Cas9 gene editing. Stem Cell Res. 2021;56:102515.","journal-title":"Stem Cell Res"},{"key":"3794_CR43","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1093\/nar\/gkz267","volume":"47","author":"VA Truong","year":"2019","unstructured":"Truong VA, Hsu M-N, Kieu Nguyen NT, Lin M-W, Shen C-C, Lin C-Y, et al. CRISPRai for simultaneous gene activation and inhibition to promote stem cell chondrogenesis and calvarial bone regeneration. Nucl Acids Res. 2019;47:e74\u2013e74.","journal-title":"Nucl Acids Res"},{"key":"3794_CR44","doi-asserted-by":"publisher","first-page":"2202271","DOI":"10.1002\/adhm.202202271","volume":"12","author":"A Bonato","year":"2023","unstructured":"Bonato A, Fisch P, Ponta S, Fercher D, Manninen M, Weber D, et al. Engineering inflammation-resistant cartilage: bridging gene therapy and tissue engineering. Adv Healthc Mater. 2023;12:2202271.","journal-title":"Adv Healthc Mater"},{"key":"3794_CR45","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1089\/ten.tea.2020.0062","volume":"26","author":"N Farhang","year":"2020","unstructured":"Farhang N, Davis B, Weston J, Ginley-Hidinger M, Gertz J, Bowles RD. Synergistic CRISPRa-regulated chondrogenic extracellular matrix deposition without exogenous growth factors. Tissue Eng Part A. 2020;26:1169\u201379.","journal-title":"Tissue Eng Part A"},{"key":"3794_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13287-020-01597-8","volume":"11","author":"A Dicks","year":"2020","unstructured":"Dicks A, Wu C-L, Steward N, Adkar SS, Gersbach CA, Guilak F. Prospective isolation of chondroprogenitors from human iPSCs based on cell surface markers identified using a CRISPR-Cas9-generated reporter. Stem Cell Res Ther. 2020;11:66.","journal-title":"Stem Cell Res Ther"},{"key":"3794_CR47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1089\/ten.tea.2021.0053","volume":"28","author":"Y Okutani","year":"2022","unstructured":"Okutani Y, Abe K, Yamashita A, Morioka M, Matsuda S, Tsumaki N. Generation of monkey induced pluripotent stem cell-derived cartilage lacking major histocompatibility complex class I molecules on the cell surface. Tissue Eng Part A. 2022;28:94\u2013106.","journal-title":"Tissue Eng Part A"},{"key":"3794_CR48","doi-asserted-by":"publisher","first-page":"e71154","DOI":"10.7554\/eLife.71154","volume":"12","author":"AR Dicks","year":"2023","unstructured":"Dicks AR, Maksaev GI, Harissa Z, Savadipour A, Tang R, Steward N, et al. Skeletal dysplasia-causing TRPV4 mutations suppress the hypertrophic differentiation of human iPSC-derived chondrocytes. Elife. 2023;12:e71154.","journal-title":"Elife"},{"key":"3794_CR49","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/s41467-023-36408-0","volume":"14","author":"K Abe","year":"2023","unstructured":"Abe K, Yamashita A, Morioka M, Horike N, Takei Y, Koyamatsu S, et al. Engraftment of allogeneic iPS cell-derived cartilage organoid in a primate model of articular cartilage defect. Nat Commun. 2023;14:804.","journal-title":"Nat Commun"},{"key":"3794_CR50","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1089\/ten.tea.2016.0189","volume":"22","author":"T Kimura","year":"2016","unstructured":"Kimura T, Yamashita A, Ozono K, Tsumaki N. Limited immunogenicity of human induced pluripotent stem cell-derived cartilages. Tissue Eng Part A. 2016;22:1367\u201375.","journal-title":"Tissue Eng Part A"},{"key":"3794_CR51","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.actbio.2021.04.008","volume":"128","author":"JF Crispim","year":"2021","unstructured":"Crispim JF, Ito K. De novo neo-hyaline-cartilage from bovine organoids in viscoelastic hydrogels. Acta Biomater. 2021;128:236\u201349.","journal-title":"Acta Biomater"},{"key":"3794_CR52","doi-asserted-by":"publisher","first-page":"272481","DOI":"10.1101\/2021.09.21.461213","volume":"2014","author":"M Li","year":"2021","unstructured":"Li M, Abrahante JE, Vegoe A, Chai YW, Lindborg B, Toth F, et al. Self-organized emergence of hyaline cartilage in hiPSC-derived multi-tissue organoids. Cell Biol. 2021;2014:272481. https:\/\/doi.org\/10.1101\/2021.09.21.461213.","journal-title":"Cell Biol"},{"key":"3794_CR53","doi-asserted-by":"publisher","first-page":"120820","DOI":"10.1016\/j.biomaterials.2021.120820","volume":"273","author":"GN Hall","year":"2021","unstructured":"Hall GN, Tam WL, Andrikopoulos KS, Casas-Fraile L, Voyiatzis GA, Geris L, et al. Patterned, organoid-based cartilaginous implants exhibit zone specific functionality forming osteochondral-like tissues in vivo. Biomaterials. 2021;273:120820.","journal-title":"Biomaterials"},{"key":"3794_CR54","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1089\/ten.tea.2020.0273","volume":"27","author":"SK O\u2019Connor","year":"2021","unstructured":"O\u2019Connor SK, Katz DB, Oswald SJ, Groneck L, Guilak F. Formation of osteochondral organoids from murine induced pluripotent stem cells. Tissue Eng Part A. 2021;27:1099\u2013109.","journal-title":"Tissue Eng Part A"},{"key":"3794_CR55","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1186\/s13287-021-02580-7","volume":"12","author":"WL Tam","year":"2021","unstructured":"Tam WL, Freitas Mendes L, Chen X, Lesage R, Van Hoven I, Leysen E, et al. Human pluripotent stem cell-derived cartilaginous organoids promote scaffold-free healing of critical size long bone defects. Stem Cell Res Ther. 2021;12:513.","journal-title":"Stem Cell Res Ther"},{"key":"3794_CR56","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.tibtech.2023.06.003","volume":"41","author":"H Vignes","year":"2023","unstructured":"Vignes H, Smaida R, Conzatti G, Hua G, Benkirane-Jessel N. Custom-made meniscus biofabrication. Trends Biotechnol. 2023;41:1467\u201370.","journal-title":"Trends Biotechnol"},{"key":"3794_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2015.00002\/abstract","author":"VK Singh","year":"2015","unstructured":"Singh VK, Kalsan M, Kumar N, Saini A, Chandra R. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery. Front Cell Dev Biol. 2015. https:\/\/doi.org\/10.3389\/fcell.2015.00002\/abstract.","journal-title":"Front Cell Dev Biol"},{"key":"3794_CR58","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3390\/cells11030529","volume":"11","author":"MS Lach","year":"2022","unstructured":"Lach MS, Rosochowicz MA, Richter M, Jagie\u0142\u0142o I, Suchorska WM, Trzeciak T. The induced pluripotent stem cells in articular cartilage regeneration and disease modelling: are we ready for their clinical use? Cells. 2022;11:529.","journal-title":"Cells"},{"key":"3794_CR59","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1089\/scd.2014.0014","volume":"23","author":"B Saitta","year":"2014","unstructured":"Saitta B, Passarini J, Sareen D, Ornelas L, Sahabian A, Argade S, et al. Patient-derived skeletal dysplasia induced pluripotent stem cells display abnormal chondrogenic marker expression and regulation by BMP2 and TGF\u03b21. Stem Cells Dev. 2014;23:1464\u201378.","journal-title":"Stem Cells Dev"},{"key":"3794_CR60","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/art.38912","volume":"67","author":"K Yokoyama","year":"2015","unstructured":"Yokoyama K, Ikeya M, Umeda K, Oda H, Nodomi S, Nasu A, et al. Enhanced chondrogenesis of induced pluripotent stem cells from patients with neonatal-onset multisystem inflammatory disease occurs via the caspase 1\u2013independent cAMP\/protein kinase A\/CREB pathway. Arthritis Rheumatol. 2015;67:302\u201314.","journal-title":"Arthritis Rheumatol"},{"key":"3794_CR61","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.5966\/sctm.2015-0384","volume":"5","author":"M Xu","year":"2016","unstructured":"Xu M, Stattin E-L, Shaw G, Heineg\u00e5rd D, Sullivan G, Wilmut I, et al. Chondrocytes derived from mesenchymal stromal cells and induced pluripotent cells of patients with familial osteochondritis dissecans exhibit an endoplasmic reticulum stress response and defective matrix assembly. Stem Cells Transl Med. 2016;5:1171\u201381.","journal-title":"Stem Cells Transl Med"},{"key":"3794_CR62","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/jbmr.3098","volume":"32","author":"JL Esseltine","year":"2017","unstructured":"Esseltine JL, Shao Q, Brooks C, Sampson J, Betts DH, S\u00e9guin CA, et al. Connexin43 mutant patient-derived induced pluripotent stem cells exhibit altered differentiation potential. J Bone Miner Res Off J Am Soc Bone Miner Res. 2017;32:1368\u201385.","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"3794_CR63","doi-asserted-by":"publisher","first-page":"e2211510120","DOI":"10.1073\/pnas.2211510120","volume":"120","author":"SR Lamand\u00e9","year":"2023","unstructured":"Lamand\u00e9 SR, Ng ES, Cameron TL, Kung LHW, Sampurno L, Rowley L, et al. Modeling human skeletal development using human pluripotent stem cells. Proc Natl Acad Sci. 2023;120:e2211510120.","journal-title":"Proc Natl Acad Sci"},{"key":"3794_CR64","doi-asserted-by":"publisher","first-page":"044103","DOI":"10.1088\/1758-5090\/ac1c99","volume":"13","author":"A Nakamura","year":"2021","unstructured":"Nakamura A, Murata D, Fujimoto R, Tamaki S, Nagata S, Ikeya M, et al. Bio-3D printing iPSC-derived human chondrocytes for articular cartilage regeneration. Biofabrication. 2021;13:044103.","journal-title":"Biofabrication"},{"key":"3794_CR65","doi-asserted-by":"publisher","first-page":"204173142211146","DOI":"10.1177\/20417314221114616","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang M, Niibe K, Kondo T, Limraksasin P, Okawa H, Miao X, et al. Rapid and efficient generation of cartilage pellets from mouse induced pluripotent stem cells by transcriptional activation of BMP-4 with shaking culture. J Tissue Eng. 2022;13:20417314221114616.","journal-title":"J Tissue Eng"},{"key":"3794_CR66","doi-asserted-by":"publisher","first-page":"9514719","DOI":"10.1155\/2017\/9514719","volume":"2017","author":"S Kotaka","year":"2017","unstructured":"Kotaka S, Wakitani S, Shimamoto A, Kamei N, Sawa M, Adachi N, et al. Magnetic targeted delivery of induced pluripotent stem cells promotes articular cartilage repair. Stem Cells Int. 2017;2017:9514719.","journal-title":"Stem Cells Int"},{"key":"3794_CR67","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/jor.20402","volume":"25","author":"R Siddappa","year":"2007","unstructured":"Siddappa R, Licht R, Van Blitterswijk C, De Boer J. Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering. J Orthop Res. 2007;25:1029\u201341.","journal-title":"J Orthop Res"},{"key":"3794_CR68","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1007\/s13238-012-2107-5","volume":"3","author":"S-L Yang","year":"2012","unstructured":"Yang S-L, Harnish E, Leeuw T, Dietz U, Batchelder E, Wright PS, et al. Compound screening platform using human induced pluripotent stem cells to identify small molecules that promote chondrogenesis. Protein Cell. 2012;3:934\u201342.","journal-title":"Protein Cell"},{"key":"3794_CR69","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1002\/art.38780","volume":"66","author":"VP Willard","year":"2014","unstructured":"Willard VP, Diekman BO, Sanchez-Adams J, Christoforou N, Leong KW, Guilak F. Use of cartilage derived from murine induced pluripotent stem cells for osteoarthritis drug screening. Arthritis Rheumatol. 2014;66:3062\u201372.","journal-title":"Arthritis Rheumatol"},{"key":"3794_CR70","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/1750-1172-8-190","volume":"8","author":"Y Matsumoto","year":"2013","unstructured":"Matsumoto Y, Hayashi Y, Schlieve CR, Ikeya M, Kim H, Nguyen TD, et al. Induced pluripotent stem cells from patients with human fibrodysplasia ossificans progressiva show increased mineralization and cartilage formation. Orphanet J Rare Dis. 2013;8:190.","journal-title":"Orphanet J Rare Dis"},{"key":"3794_CR71","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nature13775","volume":"513","author":"A Yamashita","year":"2014","unstructured":"Yamashita A, Morioka M, Kishi H, Kimura T, Yahara Y, Okada M, et al. Statin treatment rescues FGFR3 skeletal dysplasia phenotypes. Nature. 2014;513:507\u201311.","journal-title":"Nature"},{"key":"3794_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/8867349","volume":"2020","author":"Y-H Chang","year":"2020","unstructured":"Chang Y-H, Wu K-C, Ding D-C. Induced pluripotent stem cell-differentiated chondrocytes repair cartilage defect in a rabbit osteoarthritis model. Stem Cells Int. 2020;2020:1\u201316.","journal-title":"Stem Cells Int."},{"key":"3794_CR73","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.3390\/ijms19092700","volume":"19","author":"M Lammi","year":"2018","unstructured":"Lammi M, Piltti J, Prittinen J, Qu C. Challenges in fabrication of tissue-engineered cartilage with correct cellular colonization and extracellular matrix assembly. Int J Mol Sci. 2018;19:2700.","journal-title":"Int J Mol Sci"},{"key":"3794_CR74","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/dgd.12706","volume":"63","author":"A Yamashita","year":"2021","unstructured":"Yamashita A, Tsumaki N. Recent progress of animal transplantation studies for treating articular cartilage damage using pluripotent stem cells. Dev Growth Differ. 2021;63:72\u201381.","journal-title":"Dev Growth Differ"},{"key":"3794_CR75","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3892\/etm.2017.4474","volume":"14","author":"X Xu","year":"2017","unstructured":"Xu X, Shi D, Liu Y, Yao Y, Dai J, Xu Z, et al. In vivo repair of full-thickness cartilage defect with human iPSC-derived mesenchymal progenitor cells in a rabbit model. Exp Ther Med. 2017;14:239\u201345.","journal-title":"Exp Ther Med"},{"key":"3794_CR76","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1016\/j.biomaterials.2014.01.009","volume":"35","author":"J-Y Ko","year":"2014","unstructured":"Ko J-Y, Kim K-I, Park S, Im G-I. In vitro chondrogenesis and in vivo repair of osteochondral defect with human induced pluripotent stem cells. Biomaterials. 2014;35:3571\u201381.","journal-title":"Biomaterials"},{"key":"3794_CR77","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3727\/096368913X667709","volume":"23","author":"X Liang","year":"2014","unstructured":"Liang X, Ding Y, Zhang Y, Tse H-F, Lian Q. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transpl. 2014;23:1045\u201359.","journal-title":"Cell Transpl"},{"key":"3794_CR78","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13287-017-0510-9","volume":"8","author":"Y Zhu","year":"2017","unstructured":"Zhu Y, Wang Y, Zhao B, Niu X, Hu B, Li Q, et al. Comparison of exosomes secreted by induced pluripotent stem cell-derived mesenchymal stem cells and synovial membrane-derived mesenchymal stem cells for the treatment of osteoarthritis. Stem Cell Res Ther. 2017;8:64.","journal-title":"Stem Cell Res Ther"},{"key":"3794_CR79","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s13287-021-02362-1","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun Y, Zhang W, Li X. Induced pluripotent stem cell-derived mesenchymal stem cells deliver exogenous miR-105-5p via small extracellular vesicles to rejuvenate senescent nucleus pulposus cells and attenuate intervertebral disc degeneration. Stem Cell Res Ther. 2021;12:286.","journal-title":"Stem Cell Res Ther"},{"key":"3794_CR80","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2217\/rme-2016-0057","volume":"11","author":"NF Blair","year":"2016","unstructured":"Blair NF, Barker RA. Making it personal: the prospects for autologous pluripotent stem cell-derived therapies. Regen Med. 2016;11:423\u20135.","journal-title":"Regen Med"},{"key":"3794_CR81","doi-asserted-by":"publisher","first-page":"e12938","DOI":"10.1111\/cpr.12938","volume":"53","author":"L Yan","year":"2020","unstructured":"Yan L, Wu Y, Li L, Wu J, Zhao F, Gao Z, et al. Clinical analysis of human umbilical cord mesenchymal stem cell allotransplantation in patients with premature ovarian insufficiency. Cell Prolif. 2020;53:e12938.","journal-title":"Cell Prolif"},{"key":"3794_CR82","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1093\/stcltm\/szac065","volume":"11","author":"JH Shin","year":"2022","unstructured":"Shin JH, Ryu C-M, Yu HY, Park J, Kang AR, Shin JM, et al. Safety of human embryonic stem cell-derived mesenchymal stem cells for treating interstitial cystitis: a phase I study. Stem Cells Transl Med. 2022;11:1010\u201320.","journal-title":"Stem Cells Transl Med"},{"key":"3794_CR83","doi-asserted-by":"publisher","first-page":"27586","DOI":"10.1021\/acsami.3c03117","volume":"15","author":"B Guo","year":"2023","unstructured":"Guo B, Duan Y, Li Z, Tian Y, Cheng X, Liang C, et al. High-strength cell sheets and vigorous hydrogels from mesenchymal stem cells derived from human embryonic stem cells. ACS Appl Mater Interfaces. 2023;15:27586\u201399.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3794_CR84","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41591-020-1050-x","volume":"26","author":"AJC Bloor","year":"2020","unstructured":"Bloor AJC, Patel A, Griffin JE, Gilleece MH, Radia R, Yeung DT, et al. Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study. Nat Med. 2020;26:1720\u20135.","journal-title":"Nat Med"},{"key":"3794_CR85","doi-asserted-by":"publisher","first-page":"S255","DOI":"10.1016\/j.bbmt.2018.12.258","volume":"25","author":"JEJ Rasko","year":"2019","unstructured":"Rasko JEJ, Patel A, Griffin JE, Gilleece MH, Radia R, Yeung DT, et al. Results of the first completed clinical trial of an iPSC-derived product: CYP-001 in steroid-resistant acute GvHD. Biol Blood Marrow Transpl. 2019;25:S255\u20136.","journal-title":"Biol Blood Marrow Transpl"},{"key":"3794_CR86","doi-asserted-by":"publisher","first-page":"e056382","DOI":"10.1136\/bmjopen-2021-056382","volume":"11","author":"X Liu","year":"2021","unstructured":"Liu X, Robbins S, Wang X, Virk S, Schuck K, Deveza LA, et al. Efficacy and cost-effectiveness of stem cell injections for symptomatic relief and structural improvement in people with tibiofemoral knee OsteoaRthritis: protocol for a randomised placebo-controlled trial (the SCUlpTOR trial). BMJ Open. 2021;11:e056382.","journal-title":"BMJ Open"},{"key":"3794_CR87","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.biomaterials.2018.11.014","volume":"192","author":"V Graceffa","year":"2019","unstructured":"Graceffa V, Vinatier C, Guicheux J, Stoddart M, Alini M, Zeugolis DI. Chasing chimeras\u2013the elusive stable chondrogenic phenotype. Biomaterials. 2019;192:199\u2013225.","journal-title":"Biomaterials"},{"key":"3794_CR88","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3390\/bioengineering10070857","volume":"10","author":"Z Wang","year":"2023","unstructured":"Wang Z. Assessing tumorigenicity in stem cell-derived therapeutic products: a critical step in safeguarding regenerative medicine. Bioengineering. 2023;10:857.","journal-title":"Bioengineering"},{"key":"3794_CR89","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s41232-023-00307-0","volume":"43","author":"K Abe","year":"2023","unstructured":"Abe K, Tsumaki N. Regeneration of joint surface defects by transplantation of allogeneic cartilage: application of iPS cell-derived cartilage and immunogenicity. Inflamm Regen. 2023;43:56.","journal-title":"Inflamm Regen"},{"key":"3794_CR90","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2220\/biomedres.36.179","volume":"36","author":"T Saito","year":"2015","unstructured":"Saito T, Yano F, Mori D, Kawata M, Hoshi K, Takato T, et al. Hyaline cartilage formation and tumorigenesis of implanted tissues derived from human induced pluripotent stem cells. Biomed Res. 2015;36:179\u201386.","journal-title":"Biomed Res"},{"key":"3794_CR91","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.4252\/wjsc.v13.i8.1094","volume":"13","author":"V Dupuis","year":"2021","unstructured":"Dupuis V, Oltra E. Methods to produce induced pluripotent stem cell-derived mesenchymal stem cells: Mesenchymal stem cells from induced pluripotent stem cells. World J Stem Cells. 2021;13:1094\u2013111.","journal-title":"World J Stem Cells"},{"key":"3794_CR92","doi-asserted-by":"publisher","first-page":"149146","DOI":"10.1016\/j.bbrc.2023.149146","volume":"687","author":"Y Fujisawa","year":"2023","unstructured":"Fujisawa Y, Takao T, Yamada D, Takarada T. Development of cartilage tissue using a stirred bioreactor and human iPSC-derived limb bud mesenchymal cells. Biochem Biophys Res Commun. 2023;687:149146.","journal-title":"Biochem Biophys Res Commun"},{"key":"3794_CR93","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1002\/sctm.21-0151","volume":"10","author":"RE Rogers","year":"2021","unstructured":"Rogers RE, Haskell A, White BP, Dalal S, Lopez M, Tahan D, et al. A scalable system for generation of mesenchymal stem cells derived from induced pluripotent cells employing bioreactors and degradable microcarriers. Stem Cells Transl Med. 2021;10:1650\u201365.","journal-title":"Stem Cells Transl Med"},{"key":"3794_CR94","doi-asserted-by":"publisher","first-page":"5728","DOI":"10.3390\/ijms22115728","volume":"22","author":"CP Vieira","year":"2021","unstructured":"Vieira CP, McCarrel TM, Grant MB. Novel methods to mobilize, isolate, and expand mesenchymal stem cells. Int J Mol Sci. 2021;22:5728.","journal-title":"Int J Mol Sci"},{"key":"3794_CR95","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.3390\/pr11102938","volume":"11","author":"L Herbst","year":"2023","unstructured":"Herbst L, Groten F, Murphy M, Shaw G, Nie\u00dfing B, Schmitt RH. Automated production at scale of induced pluripotent stem cell-derived mesenchymal stromal cells, chondrocytes and extracellular vehicles: towards real-time release. Processes. 2023;11:2938.","journal-title":"Processes"},{"key":"3794_CR96","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/471046a","volume":"471","author":"MF Pera","year":"2011","unstructured":"Pera MF. The dark side of induced pluripotency. Nature. 2011;471:46\u20137.","journal-title":"Nature"},{"key":"3794_CR97","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12015-016-9680-6","volume":"13","author":"M Yoshihara","year":"2017","unstructured":"Yoshihara M, Hayashizaki Y, Murakawa Y. Genomic Instability of iPSCs: challenges towards their clinical applications. Stem Cell Rev Rep. 2017;13:7\u201316.","journal-title":"Stem Cell Rev Rep"},{"key":"3794_CR98","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/474165a","volume":"474","author":"E Apostolou","year":"2011","unstructured":"Apostolou E, Hochedlinger K. iPS cells under attack. Nature. 2011;474:165\u20136.","journal-title":"Nature"},{"key":"3794_CR99","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3389\/fimmu.2017.00645","volume":"8","author":"X Liu","year":"2017","unstructured":"Liu X, Li W, Fu X, Xu Y. The immunogenicity and immune tolerance of pluripotent stem cell derivatives. Front Immunol. 2017;8:645.","journal-title":"Front Immunol"},{"key":"3794_CR100","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/5584_2017_141","volume-title":"Cell biology and translational medicine","author":"C Murphy","year":"2017","unstructured":"Murphy C, Mobasheri A, T\u00e1ncos Z, Kobol\u00e1k J, Dinny\u00e9s A. The potency of induced pluripotent stem cells in cartilage regeneration and osteoarthritis treatment. In: Turksen K, editor. Cell biology and translational medicine, vol. 1. Cham: Springer International Publishing; 2017. p. 55\u201368."},{"key":"3794_CR101","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1038\/s41598-020-61405-4","volume":"10","author":"IG Kim","year":"2020","unstructured":"Kim IG, Park SA, Lee S-H, Choi JS, Cho H, Lee SJ, et al. Transplantation of a 3D-printed tracheal graft combined with iPS cell-derived MSCs and chondrocytes. Sci Rep. 2020;10:4326.","journal-title":"Sci Rep"},{"key":"3794_CR102","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, et al. A more efficient method to generate integration-free human iPS cells. Nat Methods. 2011;8:409\u201312.","journal-title":"Nat Methods"},{"key":"3794_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9079538","volume":"2018","author":"M Lo Monaco","year":"2018","unstructured":"Lo Monaco M, Merckx G, Ratajczak J, Gervois P, Hilkens P, Clegg P, et al. Stem cells for cartilage repair: preclinical studies and insights in translational animal models and outcome measures. Stem Cells Int. 2018;2018:1\u201322.","journal-title":"Stem Cells Int"},{"key":"3794_CR104","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.1038\/s41598-020-61071-6","volume":"10","author":"R Castro-Vi\u00f1uelas","year":"2020","unstructured":"Castro-Vi\u00f1uelas R, Sanjurjo-Rodr\u00edguez C, Pi\u00f1eiro-Ramil M, Hermida-G\u00f3mez T, Rodr\u00edguez-Fern\u00e1ndez S, Oreiro N, et al. Generation and characterization of human induced pluripotent stem cells (iPSCs) from hand osteoarthritis patient-derived fibroblasts. Sci Rep. 2020;10:4272.","journal-title":"Sci Rep"},{"key":"3794_CR105","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3390\/cells9030582","volume":"9","author":"YA Rim","year":"2020","unstructured":"Rim YA, Nam Y, Park N, Jung H, Lee K, Lee J, et al. Chondrogenic differentiation from induced pluripotent stem cells using non-viral minicircle vectors. Cells. 2020;9:582.","journal-title":"Cells"},{"key":"3794_CR106","doi-asserted-by":"publisher","first-page":"20915","DOI":"10.1038\/s41598-020-77345-y","volume":"10","author":"T Ozaki","year":"2020","unstructured":"Ozaki T, Kawamoto T, Iimori Y, Takeshita N, Yamagishi Y, Nakamura H, et al. Evaluation of FGFR inhibitor ASP5878 as a drug candidate for achondroplasia. Sci Rep. 2020;10:20915.","journal-title":"Sci Rep"},{"key":"3794_CR107","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/cells10020317","volume":"10","author":"YA Rim","year":"2021","unstructured":"Rim YA, Nam Y, Park N, Lee K, Jung H, Jung SM, et al. Characterization of early-onset finger osteoarthritis-like condition using patient-derived induced pluripotent stem cells. Cells. 2021;10:317.","journal-title":"Cells"},{"key":"3794_CR108","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.stemcr.2021.01.014","volume":"16","author":"Y Pretemer","year":"2021","unstructured":"Pretemer Y, Kawai S, Nagata S, Nishio M, Watanabe M, Tamaki S, et al. Differentiation of hypertrophic chondrocytes from human iPSCs for the in vitro modeling of chondrodysplasias. Stem Cell Rep. 2021;16:610\u201325.","journal-title":"Stem Cell Rep"},{"key":"3794_CR109","doi-asserted-by":"publisher","first-page":"eaba4226","DOI":"10.1126\/scitranslmed.aba4226","volume":"13","author":"T Kimura","year":"2021","unstructured":"Kimura T, Bosakova M, Nonaka Y, Hruba E, Yasuda K, Futakawa S, et al. An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice. Sci Transl Med. 2021;13:eaba4226.","journal-title":"Sci Transl Med"},{"key":"3794_CR110","doi-asserted-by":"publisher","first-page":"045015","DOI":"10.1088\/1758-5090\/ac1e76","volume":"13","author":"SJ Lee","year":"2021","unstructured":"Lee SJ, Nam Y, Rim YA, Lee K, Ju JH, Kim DS. Perichondrium-inspired permeable nanofibrous tube well promoting differentiation of hiPSC-derived pellet toward hyaline-like cartilage pellet. Biofabrication. 2021;13:045015.","journal-title":"Biofabrication"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03794-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-024-03794-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03794-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T15:05:02Z","timestamp":1719414302000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-024-03794-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":110,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3794"],"URL":"https:\/\/doi.org\/10.1186\/s13287-024-03794-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,26]]},"assertion":[{"value":"28 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}